VRTX

1
Vertex pharmaceutical
Stock :NASDAQ
: Healthcare
: Biotechnology
Miracle Viewer
  19/08/2025 01:00 GMT+2
1.49
414.77975
386.42767
-0.124
-0.001
-0.073
0.055

Ruota il tuo smartphone per vedere un grafico migliore
Ruota il tuo smartphone per vedere un grafico migliore

Operativity type

LONG
Profit %
88.94 %
Timeframe
H 1
Duration
13
VRTX
Sector: Health Technology
Industry: Biotechnology
Employees: 3400

Vertex Pharmaceuticals, Inc. is a global biotechnology company.

It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.

The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.

The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.